Showing results (51-60 of 279) with videos related to
Sort By:
Pageof 28
Clinical Sarcoma Research|November 21, 2017
A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the USVictor M Villalobos, Stacey DaCosta Byfield, Sameer R Ghate, et al.Clinical Lung Cancer|August 12, 2022
Oncogene Overlap Analysis of Circulating Cell-free Tumor DNA to Explore the Appropriate Criteria for Defining MET Copy Number-Driven Lung CancerDavid C C Tsui, Leylah M Drusbosky, Sara Wienke, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 27, 2010
Molecular origins of lung cancer: prospects for personalized prevention and therapyEric B Haura, D Ross Camidge, Karen Reckamp, et al.Cancer|January 3, 2013
Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancerAndrew J Weickhardt, Dara L Aisner, Wilbur A Franklin, et al.Cancer Chemotherapy and Pharmacology|November 23, 2006
A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteersD Ross Camidge, Dominic Smethurst, Jim Growcott, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2019
DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung CancerKurtis D Davies, Aprille Lomboy, Carolyn A Lawrence, et al.Future Oncology (London, England)|May 28, 2021
Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trialsD Ross Camidge, Haeseong Park, Karen E Smoyer, et al.Cancer|November 22, 2013
Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinibEvelyn M Brosnan, Andrew J Weickhardt, Xian Lu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2011
Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancerNeha P Amin, Moyed Miften, Brian Kavanagh, et al.Clinical Lung Cancer|September 22, 2024
A Phase I Open-Label Study of Cediranib Plus Etoposide and Cisplatin as First-Line Therapy for Patients With Extensive-Stage Small-Cell Lung Cancer or Metastatic Neuroendocrine Non-Small-Cell Lung CancerKyle F Concannon, Bonnie S Glisson, Robert C Doebele, et al.Pageof 28